MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, CYTK has $1,273,478K in assets. $2,100,046K in debts. $129,843K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
421.45%
Quick Ratio
421.37%
Cash Ratio
65.19%
Debt to Asset Ratio
164.91%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Long-term investments
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Convertible notes, net
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
129,843 122,518 225,467 74,940
Short-term investments
688,707 759,703 737,068 783,195
Accounts receivable
6,827 17,764 1,808 8,410
Inventories
154 ---
Prepaid expenses and other current assets
13,934 16,990 13,006 19,997
Total current assets
839,465 916,975 977,349 886,542
Long-term investments
254,719 335,048 288,817 178,201
Total property and equipment
-126,495 --
Less accumulated depreciation
-47,301 --
Property and equipment, net
82,438 79,194 76,001 70,219
Operating lease right-of-use assets
74,545 75,979 77,580 76,120
Inventories, long-term
3,843 ---
Other assets
18,468 17,341 16,810 14,553
Total assets
1,273,478 1,424,537 1,436,557 1,225,635
Accounts payable
24,709 22,337 22,084 16,228
Accrued liabilities
68,863 83,278 61,633 52,315
Short-term operating lease liabilities
20,960 19,111 20,647 19,585
Current portion of convertible and long-term debt
44,808 41,181 17,280 14,400
Derivative liabilities measured at fair value
29,600 31,100 16,900 17,600
Deferred revenue
1,653 1,612 1,612 1,344
Other current liabilities
8,592 3,833 1,988 9,592
Total current liabilities
199,185 202,452 142,144 131,064
Term loans, net
247,209 246,384 158,747 159,058
Convertible notes, principal amount
--911,662 561,133
Less unamortized debt issuance costs on the convertible notes
--22,138 7,146
Convertible notes, net
870,511 869,597 889,524 553,987
Liabilities related to revenue participation right purchase agreements, net
539,106 520,559 504,498 489,503
Long-term operating lease liabilities
105,235 107,970 110,655 111,028
Liabilities related to rpi transactions measured at fair value
138,800 137,200 150,500 147,700
Other non-current liabilities
--1,612 2,015
Total liabilities
2,100,046 2,084,162 1,957,680 1,594,355
Preferred stock
0 -0 0
Common stock
124 123 122 119
Additional paid-in capital
2,867,670 2,826,341 2,782,409 2,628,829
Accumulated other comprehensive (loss) income
-1,612 630 34 -158
Accumulated deficit
-3,692,750 -3,486,719 -3,303,688 -2,997,510
Total stockholders' deficit
-826,568 -659,625 -521,123 -368,720
Total liabilities and stockholders' deficit
1,273,478 1,424,537 1,436,557 1,225,635
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$688,707K (-20.34%↓ Y/Y)Cash and cashequivalents$129,843K (76.23%↑ Y/Y)Prepaid expenses andother current assets$13,934K (-11.94%↓ Y/Y)Accounts receivable$6,827K (239.31%↑ Y/Y)Inventories$154K Total current assets$839,465K (-12.19%↓ Y/Y)Long-term investments$254,719K (69.04%↑ Y/Y)Property and equipment,net$82,438K (22.72%↑ Y/Y)Operating leaseright-of-use assets$74,545K (-3.74%↓ Y/Y)Other assets$18,468K (45.45%↑ Y/Y)Inventories, long-term$3,843K Total assets$1,273,478K (0.75%↑ Y/Y)Accumulated deficit-$3,692,750K (-28.98%↓ Y/Y)Accumulated othercomprehensive (loss) income-$1,612K (-204.34%↓ Y/Y)Total liabilities andstockholders' deficit$1,273,478K (0.75%↑ Y/Y)Total stockholders'deficit-$826,568K (-210.26%↓ Y/Y)Additional paid-in capital$2,867,670K (10.50%↑ Y/Y)Common stock$124K (4.20%↑ Y/Y)Total liabilities$2,100,046K (37.22%↑ Y/Y)Convertible notes, net$870,511K (57.38%↑ Y/Y)Liabilities related torevenue participation...$539,106K (13.19%↑ Y/Y)Term loans, net$247,209K (168.63%↑ Y/Y)Total currentliabilities$199,185K (24.70%↑ Y/Y)Liabilities related to rpitransactions measured at fair...$138,800K (4.28%↑ Y/Y)Long-term operating leaseliabilities$105,235K (-7.16%↓ Y/Y)Accrued liabilities$68,863K (58.82%↑ Y/Y)Current portion ofconvertible and long-term...$44,808K (245.74%↑ Y/Y)Derivative liabilitiesmeasured at fair value$29,600K (152.99%↑ Y/Y)Accounts payable$24,709K (77.23%↑ Y/Y)Short-term operating leaseliabilities$20,960K (7.08%↑ Y/Y)Other currentliabilities$8,592K (47.58%↑ Y/Y)Deferred revenue$1,653K (-96.84%↓ Y/Y)

CYTOKINETICS INC (CYTK)

CYTOKINETICS INC (CYTK)